Applied UV, Inc. (NASDAQ:AUVI) Short Interest Update

Applied UV, Inc. (NASDAQ:AUVI) was the recipient of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 13,500 shares, a decline of 53.9% from the September 15th total of 29,300 shares. Based on an average daily volume of 310,400 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.3% of the company’s shares are short sold.

Separately, Zacks Investment Research downgraded Applied UV from a “hold” rating to a “sell” rating in a research report on Friday, August 20th.

A number of hedge funds have recently modified their holdings of the stock. Advisor Group Holdings Inc. grew its stake in Applied UV by 22.5% in the second quarter. Advisor Group Holdings Inc. now owns 27,589 shares of the company’s stock worth $271,000 after purchasing an additional 5,073 shares during the period. Geode Capital Management LLC grew its stake in Applied UV by 53.5% in the second quarter. Geode Capital Management LLC now owns 25,907 shares of the company’s stock worth $254,000 after purchasing an additional 9,024 shares during the period. Bank of Montreal Can purchased a new stake in Applied UV in the first quarter worth $193,000. Citadel Advisors LLC purchased a new stake in Applied UV in the second quarter worth $144,000. Finally, Morgan Stanley purchased a new stake in shares of Applied UV in the second quarter worth $51,000. 2.86% of the stock is currently owned by institutional investors.

AUVI opened at $5.57 on Thursday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.47 and a current ratio of 2.63. Applied UV has a 52-week low of $4.52 and a 52-week high of $35.78. The stock has a market capitalization of $52.44 million, a PE ratio of -6.33 and a beta of 0.43. The stock’s 50 day moving average price is $6.71 and its 200-day moving average price is $8.32.

Applied UV (NASDAQ:AUVI) last posted its earnings results on Sunday, August 15th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by ($0.14). Applied UV had a negative net margin of 88.95% and a negative return on equity of 54.83%. Research analysts forecast that Applied UV will post -0.57 EPS for the current fiscal year.

About Applied UV

Applied UV, Inc designs, develops, and markets air purification and infection control products in the healthcare, hospitality, commercial, municipal, and residential markets in the United States. The company offers solutions and products in air purification under the Airocide brand and label and disinfection of hard surfaces under the Lumicide brand.

Featured Article: What factors cause inflation to rise?

Receive News & Ratings for Applied UV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied UV and related companies with's FREE daily email newsletter.